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Background: The aetiology of juvenile idiopathic arthritis (JIA) is largely unknown. We have established a JIA
biobank in Melbourne, Australia called CLARITY – ChiLdhood Arthritis Risk factor Identification sTudY, with the
broad aim of identifying genomic and environmental disease risk factors. We present here study protocols, and a
comparison of socio-demographic, pregnancy, birth and early life characteristics of cases and controls collected
over the first 3 years of the study.
Methods: Cases are children aged ≤18 years with a diagnosis of JIA by 16 years. Controls are healthy children aged
≤18 years, born in the state of Victoria, undergoing a minor elective surgical procedure. Participant families provide
clinical, epidemiological and environmental data via questionnaire, and a blood sample is collected.
Results: Clinical characteristics of cases (n = 262) are similar to those previously reported. Demographically, cases
were from families of higher socio-economic status. After taking this into account, the residual pregnancy and
perinatal profiles of cases were similar to control children. No case-control differences in breastfeeding
commencement or duration were detected, nor was there evidence of increased case exposure to tobacco smoke
in utero. At interview, cases were less likely to be exposed to active parental smoking, but disease-related changes
to parent behaviour may partly underlie this.
Conclusions: We show that, after taking into account socio-economic status, CLARITY cases and controls are well
matched on basic epidemiological characteristics. CLARITY represents a new study platform with which to generate
new knowledge as to the environmental and biological risk factors for JIA.
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JIA is defined as a chronic autoimmune inflammatory
arthritis of largely unknown aetiology that begins before
16 years of age [1]. It is characterised by joint swelling,
pain or tenderness, and movement limitation not due to
a primary mechanical disorder, that persists for at least
6 weeks. Cases are classified into seven subtypes, based
on the number of joints affected and other disease
features, using the International League of Associations
for Rheumatology (ILAR) classification system. Current
treatments are aimed at reducing pain and inflammation,* Correspondence: justine.ellis@mcri.edu.au
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reproduction in any medium, provided the orbut they are largely not based on known aetiology and
are thus not optimally effective [1].
The prevalence of JIA has been estimated to fall be-
tween 0.07 and 4 per thousand Caucasian children [2].
JIA can have significant impact in terms of decreased
quality of life, physical function, and development [3].
JIA is typical of autoimmune disease, in that it is con-
sidered a complex disease, with susceptibility dependent
on a complex interplay between inherited genetic var-
iants [4], and life course exposure to adverse environ-
ments [5]. Amongst the relatively small number of
genetic risk variants robustly identified are those in the
Human Leukocyte Antigen (HLA) region, and in the
shared autoimmunity gene PTPN22 [6]. Promisingly, a
number of new gene loci have recently been reported,
including VTCN1 [7], AFF3 [8], IL2RA [9], PTPN2 [10],. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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await further confirmation by independent studies. As
we recently reviewed, less is known about the environ-
mental factors that contribute to JIA risk [5]. Recent
work identifying factors such as UVR exposure and
Vitamin D, and exposure to microbes during early
life (the hygiene hypothesis) and at disease onset, as im-
portant in developing other autoimmune diseases, pro-
vide hypothesis-generating clues for future research [5].
However, there is a paucity of study platforms available
with which to examine environmental factors, and their
interactions with gene variants.
Here, we provide detail of CLARITY, the ChiLdhood
Arthritis Risk factor Identification sTudY, established in
Melbourne, Australia, to address these knowledge gaps.
We present study design and data collection methodolo-
gies, along with recruitment, biospecimen and environ-
mental data collection rates, and clinical, demographic,
prenatal, birth and lifestyle characteristics of the
first 314 cases and 481 controls recruited to CLARITY,




All CLARITY protocols are approved by the Human
Research Ethics Committee of the Royal Children’s
Hospital, Melbourne Australia. All participants provided
written consent.
Cases are recruited during a public or private clinic
visit to the Royal Children’s Hospital (RCH), Victoria,
Australia. The RCH is located in central Melbourne, and
is the major paediatric tertiary referral hospital in the
state. An estimated 80% of all Victorian JIA cases attend
the RCH paediatric rheumatology clinic serviced by
three rheumatologists.
Case inclusion criteria are that the child is aged be-
tween 0-18 years at interview, with diagnosis of JIA by
a paediatric rheumatologist before the age of 16 years.
Exclusion criteria are the presence of major congenital
abnormalities, or illness that would forgo school attend-
ance in the one year prior to recruitment. Incident cases
are defined as children recruited within six months of
diagnosis. Prevalent cases are defined as those children
diagnosed more than 6 months before recruitment, and
since 1997. Cases were diagnosed with JIA using the
ILAR criteria [12]. Case families complete a question-
naire gathering information about the child’s birth; the
first years of life; the household and family; skin type,
sun exposure and activities; sleep habits; health pro-
blems; teeth; atopic disease; and family illness history.
Additionally, case families complete a questionnaire
gathering information about the parents, including
socio-demographic measures, ancestry, lifestyle duringthe child’s pregnancy (e.g. smoking, alcohol use), contact
with animals and sick people, illnesses, and sun exposure;
skin type; current smoking and smoking indoors near the
child. Cases provide a 9 ml peripheral blood sample.
Control recruitment
In recognition of the difficulties in obtaining a blood
specimen from population/community-based child con-
trols, controls are recruited through the Royal Children’s
Hospital Day Surgery Unit (RCH DSU).
Families are invited to participate if their child is aged
between 0-18, a patient of the RCH DSU for the pur-
poses of elective surgery, and was born in the state of
Victoria. This criterion allows the representativeness of
the hospital based control group to the Victorian paedi-
atric population to be eventually assessed via compari-
son of collected birth summary data to that collected
within the Victorian Perinatal Data Collection Unit
(VPDCU) [13]. Differences in demographic characteris-
tics of controls compared to the Victorian population as
a whole can then be accounted for during data analyses
using back-weighting adjustments, as we have used in
previous work [14]. Cases were not similarly restricted
in recognition of their more limited availability, and the
utility of all cases for genomic analyses regardless of
place of birth. Control families are excluded if the child
has major congenital abnormalities, or illness that would
forgo school attendance in the year prior to recruitment.
Control families complete questionnaires covering the
same child and parent items as for the cases. Control
children provide a 9 ml peripheral blood sample, col-
lected prior to anaesthesia.
Questionnaire data
In most instances, questionnaires are completed on the
day of recruitment in the presence of a research nurse.
Occasionally, due to time constraints, the questionnaire
is completed at home. A research nurse is made avail-
able to participants by telephone to answer queries. Data
is scanned directly into a comma separated file using the
Teleform© system.
Biobanking procedures
The peripheral blood sample is collected into EDTA and
immediately delivered to the onsite biobanking facility.
Plasma is removed within 2 hours and stored at -80°C.
Within 24 hours, peripheral blood mononuclear cells
(PBMCs) are isolated using a standard ficoll procedure,
chilled slowly to -80°C, then transferred to vapour-
phase liquid nitrogen storage to maintain cell viability.
The remaining white blood cells (mainly consisting of
granulocytes) are also isolated for extraction of genomic
DNA.
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to access Newborn Screening Cards – newborn (within
72 hours) blood spotted to card for over 99% of Victorian
births for screening of treatable disease such as phenylke-
tonuria (PKU). These cards are retained indefinitely by
Genetic Health Services Victoria (housed at RCH). Newly
developed methods allow the use of these blood spots for
analysis of potential disease biomarkers, such as vitamin D
[15], and DNA methylation [16].
Statistical analyses
In this paper we present data collected to CLARITY from
February 2008 (study commencement) until December
2010, for a comparison of collected data pertaining to
socio-demographics, lifestyle and birth between cases
and controls. Limiting data to participants recruited by
December 2010 provided a 12 month window to clarify
clinical diagnosis of JIA, prior to finalisation of data
for analysis.
Logistic regression was used to examine case-control
differences. Analyses were carried out on the full dataset,
and on the dataset restricted to cases (and controls)
born in Victoria. Unadjusted odds ratios (UOR) were
calculated. ORs for Victorian born cases vs controls
were then adjusted (AOR) for maternal socio-economic
status using SEIFA score (Socio-Economic Indexes for
Areas, a ranking of geographic postal-code areas in
terms of socio-economic characteristics, Australian
Bureau of Statistics) [17], child age, sex and Caucasian
ancestry (yes/no), and maternal age at the child’s birth.
Paternal SEFIA and age at child’s birth were not add-
itionally adjusted for since maternal and paternal
measures were highly correlated (SEIFA score r = 0.90,
p < 0.0001; age at child’s birth r = 0.70, p < 0.0001). Fur-
ther adjustment for parental age at interview did not
materially alter the ORs. A similar approach was taken for
the comparison of older (> 6 years) to younger (≤ 6 years)
diagnosed case data, except that these analyses were
carried out on all cases, and were not adjusted for child
age. A p < 0.05 was considered significant. All analyses
were performed using Stata v11 (StataCorp, College
Station, TX).
Results
Recruitment and collection statistics
Of the cases, 95% (314/330) of families that were
deemed eligible by our criteria took up an invitation
to participate. For controls identified within the RCH
DSU, we have achieved an overall recruitment rate of
89% (481/540) by face-to-face recruitment of families
following child admission procedures and prior to enter-
ing theatre.
The questionnaire was completed (or partially com-
pleted) by 87% (272/314) of cases, and 95% (458/481) ofcontrols. Plasma was collected for 91% (286/314) of
cases and 98% (471/481) of controls, and PBMCs were
collected for 86% (270/314) of cases and 90% (433/481)
of controls.
Completeness of data
Eight cases were excluded from analysis because,
although their diagnosis at recruitment was JIA, this
diagnosis had changed by commencement of data ana-
lysis. Data from two cases who withdrew from the study
was also excluded. Examination of Table 1 demonstrates
that data is not complete for all variables for the
remaining 262 cases and 458 controls who completed/
partially completed questionnaires. In general, the pro-
portion of missing data is low. However, several changes
to the questionnaires occurred following study piloting.
Variables added post-study piloting include SEIFA score,
mode of delivery, and indoor parental smoking.
Case-control data comparisons
Table 1 displays characteristics of all cases, Victorian-
born cases, and Victorian-born (all) controls. Table 2
summarises logistic regression analyses comparing Victorian-
born cases and controls for selected variables, adjusting
sequentially for mother’s SEIFA score, child measures
(age, sex, ancestry), and mother’s age at the child’s birth.
Below, we highlight some of the key findings from data
presented in these tables.
Socio-demographic data
Based on SEIFA score, mothers of Victorian-born cases
were generally more advantaged than mothers of con-
trols. Data for fathers was similar to that for mothers.
More mothers of Victorian-born cases were married
at the time of interview. There was evidence that
mothers of cases were more highly educated, but worked
fewer paid hours, than mothers of controls, following
covariate adjustments.
Parental lifestyle
Fewer mothers and fathers of Victorian-born cases
reported any smoking at the time of interview; this
difference remained significant following regression
adjustments for the mother, but not the father. The
number of reported alcoholic drinks per week at the
time of interview was not different between cases and
controls for either mothers or fathers.
Pregnancy and birth
All data collected on pregnancy and birth pertains to the
pregnancy and birth of the child recruited to the CLARITY
study.
Both mothers and fathers of Victorian-born cases were
significantly older at the time of the child’s birth.
Table 1 Comparison of basic data collected in CLARITY cases and controls
All cases Victorian-born cases Victorian-born (all) controls
n† n† n†
Basic characteristics
Child mean age at interview 262 9.5 (SD: 4.5)* 229 9.4 (SD: 4.6)* 458 7.1 (SD 4.2)
Child female 262 67.2%* 229 68.1%* 458 39.7%
Child has four Caucasian grandparents 217 87.1%* 190 90.0%* 378 79.1%
Mother’s age at interview 256 40.3 (SD: 6.0)* 224 40.5 (SD: 5.8)* 449 36.9 (SD: 6.4)
Father’s age at interview 243 43.0 (SD: 6.6)* 213 43.2 (6.5)* 398 39.4 (SD: 6.8)
Socio-demographic data
Mother’s SEIFA§ score 90 1026.7 (SD: 62.9)* 74 1030.9 (SD: 62.6)* 305 1003.7 (SD: 70.4)
Father’s SEIFA§ score 81 1026.1 (SD: 64.3)* 67 1033.6 (SD: 61.7)* 245 1006.5 (SD: 71.7)
Mother’s education
Completed year 12 257 66.2% 224 68.8% 449 71.9%
Completed postgraduate degree 202 10.4% 173 10.4% 344 10.8%
Father’s education
Completed year 12 244 57.4% 215 57.7% 399 61.4%
Completed postgraduate degree 180 12.8% 157 12.7% 275 9.8%
Mother’s marital status at interview 256 223 450
married 79.3%* 80.7%* 70.9%
divorced 7.0% 7.2% 6.2%
separated 5.1% 4.9% 6.2%
widowed 0.8% 0.5% 1.3%
de facto 2.0% 1.8% 4.9%
never married 5.9% 4.9% 10.2%
Father’s marital status at interview 246 216 401
married 84.2%* 84.3%* 75.8%
divorced 5.7% 5.6% 4.2%
separated 3.7% 3.7% 5.7%
widowed 0.8% 0.9% 0%
de facto 1.2% 1.4% 3.7%
never married 4.1% 3.7% 9.2%
don’t know 0.4% 0.5% 1.3%
Mother hours in paid work (mean) 220 23.0 (SD: 20.0) 193 22.9 (SD: 19.9) 340 20.2 (SD: 19.1)
Father hours in paid work (mean) 216 43.0 (SD: 15.1) 190 43.3 (SD: 15.1) 312 41.5 (SD: 16.5)
Mother cigarettes/day 255 222 451
none 80.0%* 79.7%* 72.7%
1-10/day 9.8% 9.9% 14.9%
11-20/day 8.2% 8.6% 10.2%
21-40/day 2.0% 1.8% 2.0%
41+/day 0% 0% 0.2%
Father cigarettes/day 242 213 397
none 78.1% 79.3%* 71.5%
1-10/day 7.9% 8.0% 10.8%
11-20/day 10.3% 9.4% 10.8%
21-40/day 2.9% 2.8% 6.3%
41+/day 0.8% 0.5% 0.5%
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Table 1 Comparison of basic data collected in CLARITY cases and controls (Continued)
Mother alcoholic drinks/wk mean (SD) 249 2.2 (SD: 3.8) 216 2.4 (SD: 4.0) 435 1.9 (SD: 3.0)
Father alcoholic drinks/wk mean (SD) 232 4.9 (SD: 6.6) 204 4.8 (SD: 6.6) 384 5.1 (SD: 7.9)
Pregnancy & Birth
Mother’s age at child’s birth (mean, yrs) 256 30.2 (SD: 4.9)* 224 30.6 (SD: 4.8)* 449 29.3 (SD: 5.3)
Father’s age at child’s birth (mean, yrs) 243 33.0 (SD: 5.7)* 213 33.4 (SD: 5.7)* 398 32.0 (SD: 6.1)
Planned pregnancy 262 79.8% 229 81.2% 456 77.6%
planned natural 73.7 75.6% 72.8%
planned assisted 6.1% 5.7% 4.8%
unplanned 20.2% 18.8% 22.4%
Child adopted 262 0% 229 0% 455 0.7%
Mother smoked during this pregnancy 256 223 448
Nil 84.0%* 83.9%* 74.6%
Less than daily 5.9% 6.3% 10.0%
1-10/day 6.3% 6.7% 9.4%
11-20/day 3.5% 3.2% 4.7%
21-40/day 0.4% 0% 1.3%
41+/day 0% 0%
Father smoked during this pregnancy 235 207 385
Nil 77.0%* 78.3%* 68.8%
Less than daily 3.0% 2.9% 4.9%
1-10/day 5.1% 5.3% 9.6%
11-20/day 11.1% 10.1% 11.4%
21-40/day 3.4% 3.4% 4.9%
41+/day 0.4% 0% 0.3%
Mother major illness during pregnancy 261 26.1% 228 25.0% 452 23.0%
Mother meds/supps during pregnancy
multivitamins 245 24.9% 215 25.1% 409 30.8%
folate 246 61.4% 216 60.7% 409 64.8%
calcium 246 10.2% 216 9.7% 409 14.9%
iron 246 35.4% 216 35.6% 409 40.3%
vitamin D 246 3.3%* 216 3.7% 409 7.8%
fish oil 246 2.9% 216 2.8% 409 6.4%
antibiotics 246 3.7% 216 3.7% 409 3.7%
other 244 11.5%* 214 11.2% 409 6.4%
Mother any alcohol during pregnancy 255 18.1% 222 19.4%* 448 18.3%
Mother any coffee during pregnancy 253 56.1%* 220 57.7%* 448 54.7%
Child’s gestation (mean, weeks) 211 39.3 (SD: 1.8) 186 39.3 (SD: 1.8) 389 39.0 (SD: 2.3)
Child mode of delivery 90 71 210
normal vaginal 63.3% 63.4% 60.0%
assisted vaginal 12.2% 12.7% 11.9%
caesarian 23.3% 22.5% 27.1%
other 1.1% 1.4% 1.0%
Child birthweight (mean, g) 225 3354.0 (SD: 613.8) 200 3357.2 (SD: 581.5) 344 3363.0 (SD: 676.9)
Child birthlength (mean, cm) 194 50.2 (SD: 3.4) 174 50.1 (SD: 3.4) 268 50.4 (SD: 3.7)
Child head circumference (mean, cm) 161 34.8 (SD: 3.0) 149 34.8 (SD: 3.1) 176 34.6 (SD: 3.1)
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Table 1 Comparison of basic data collected in CLARITY cases and controls (Continued)
Child in multiple birth 253 3.6% 221 4.1% 448 3.1%
Child birth order (all live-born sibs) mean 262 1.90 (SD:1.02) 229 1.93 (SD: 1.05) 456 1.85 (SD: 1.03)
Early Life
Child breastfeeding
any 260 85.8% 228 86.4% 454 81.3%
if any, age started (wks) (mean, SD) 217 0.3 (SD 1.6) 191 0.3 (SD 1.7) 360 0.9 (SD 5.0)
if any, weeks breastfed (mean, SD) 214 36.5 (SD 29.9) 188 36.5 (SD 30.4) 357 37.6 (SD 34.4)
Child formula feeding
age started (weeks) 194 18.2 (SD 19.9) 173 18.3 (SD 20.1) 348 16.4 (SD 16.5)
weeks formula fed 239 35.1 (SD 34.3) 210 35.9 (35.2) 433 37.2 (SD 37.1)
Child cow’s milk commence age (weeks) 221 58.8 (SD 17.6) 193 57.9 (SD 17.6)* 405 61.6 (SD 22.4)
Child solids commence age (weeks) 234 24.2 (SD 16.1) 210 23.8 (SD 16.4) 424 23.9 (SD 9.6)
Mother smokes indoors near child 241 211 216
usually 0.8% 1.0% 1.4%
sometimes 3.7% 3.8% 6.9%
never 95.4% 95.3% 91.7%
Father smokes indoors near child 231 203 192
usually 1.3% 1.0% 2.6%
sometimes 3.5% 3.5% 5.7%
never 95.2% 95.6% 91.7%
† Number of observations.
* p < 0.05 vs controls by unadjusted logistic regression. See Table 2 for adjusted data.
§ SEIFA = Socio-Economic Indexes for Areas, a measure of residential positional disadvantage based on the Australian Bureau of Statistics Census of Population
and Housing. The higher the score, the lower the disadvantage.
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born cases reported any smoking during the pregnancy,
this association persisted for fathers, but not for
mothers, following covariate adjustments.
There was some evidence of association of JIA with nutri-
tional supplementation during pregnancy. Use of vitamin D
and fish oil during pregnancy was lower in case mothers;
however, these associations were not significant for
Victorian-born participants following covariate adjustments.
No differences between cases and controls were observed
for gestation length or mode of delivery (including caesar-
ean vs non-caesarean birth). Similarly, birth weight, birth
length, head circumference and frequency of a child born
within a multiple birth were not different between the
groups. In relation to other siblings, the child’s birth order
was also not different between cases and controls.
Early life
Breastfeeding was commenced in 86% of Victorian-born
cases, and 81% of controls; these differences were not
significant. Amongst those who were breastfed, there
were no significant differences between Victorian-born
case and control children for breastfeeding duration.
Amongst those who were formula fed, there were alsono significant differences in age at commencement.
A significant difference was detected for age at cow’s
milk introduction; on average, Victorian-born cases
commenced cow’s milk at a younger age than controls.
However, this association did not persist following cov-
ariate adjustments. No differences in the age at com-
mencement of solids were detected.
The frequency of both mothers and fathers who
reported any smoking indoors near the child was lower
in Victorian-born cases compared to controls. This dif-
ference was significant following covariate adjustments
for fathers, but not for mothers. For these analyses, com-
pletion of high school by the mother was used in place
of SEIFA score as a measure of socioeconomic status,
since there was insufficient data for SEIFA score in the
model, and the two socioeconomic covariates were sig-
nificantly correlated (p < 0.0001).
Comparison of data between younger- and older-
diagnosed cases
We also considered whether differences might be evi-
dent between cases diagnosed at 6 years of age or
younger (younger diagnosed cases) and cases diagnosed
after 6 years of age (older diagnosed cases). We chose a
Table 2 Unadjusted and adjusted logistic regression odds ratios (UOR/AOR) between Victorian-born cases and controls for selected phenotypic ‘exposure’
variables
UOR (95% CI) AOR (95% CI)
Mother’s SEIFA score Child measures† Mother’s age at child’s birth
Mother’s SEIFA score* 1.01 (1.00, 1.01), p = 0.003 ** 1.01 (1.00, 1.01), p = 0.004 1.01 (1.00, 1.01), p = 0.011
Mother completed Yr12 0.86 (0.61, 1.22), p = 0.39 1.02 (0.55, 1.88), p = 0.95 2.95 (1.30, 6.68), p = 0.009 2.72 (1.19, 6.20) p = 0.017
Father completed Yr12 0.86 (0.61, 1.20), p = 0.37 0.64 (0.37, 1.11), p = 0.11 1.05 (0.55, 1.98), p = 0.89 0.98 (0.51, 1.86), p = 0.94
Mother married at interview 1.71 (1.15, 2.52), p = 0.007 1.82 (0.96, 3.45), p = 0.065 2.94 (1.32, 6.57), p = 0.009 2.62 (1.16, 5.92), p = 0.020
Father married at interview 1.67 (1.08, 2.59), p = 0.022 2.11 (1.02, 4.39), p = 0.044 2.78 (1.20, 6.43), p = 0.017 2.48 (1.06, 5.80), p = 0.036
Mother hours in paid work* 1.01 (1.00, 1.02), p = 0.12 0.99 (0.98, 1.01), p = 0.40 0.98 (0.96, 1.00), p = 0.078 0.98 (0.96, 1.00), p = 0.037
Father hours in paid work* 1.01 (1.00, 1.02), p = 0.23 1.01 (0.99, 1.03), p = 0.50 1.02 (0.99, 1.04), p = 0.17 1.02 (0.99, 1.04), p = 0.16
Mother currently smokes 0.68 (0.46, 1.00), p = 0.049 0.45 (0.22, 0.92), p = 0.029 0.25 (0.095, 0.63), p = 0.003 0.27 (0.11, 0.71), p = 0.008
Father currently smokes 0.65 (0.44, 0.97), p = 0.036 0.68 (0.36, 1.30), p = 0.25 0.69 (0.34, 1.41), p = 0.31 0.80 (0.39, 1.64), p = 0.54
Mother’s age at child’s birth* 1.05 (1.02, 1.08), p = 0.002 1.07 (1.01, 1.12), p = 0.016 1.08 (1.02, 1.15), p = 0.011 **
Father’s age at child’s birth* 1.04 (1.01, 1.07), p = 0.009 1.04 (1.00, 1.09), p = 0.067 1.06 (1.01, 1.11), p = 0.025 **
Mother smoked during child’s pregnancy (any) 0.56 (0.37, 0.85), p = 0.007 0.77 (0.41, 1.45), p = 0.43 0.52 (0.24, 1.12), p = 0.094 0.61 (0.28, 1.33), p = 0.21
Father smoked during child’s pregnancy (any) 0.61 (0.41, 0.91), p = 0.015 0.52 (0.26, 0.97), p = 0.039 0.42 (0.20, 0.89), p = 0.024 0.46 (0.21, 0.99), p = 0.047
Mother took Vitamin D during child’s pregnancy 0.45 (0.21, 1.00), p = 0.05 0.16 (0.02, 1.21), p = 0.075 0.21 (0.03, 1.69), p = 0.14 0.26 (0.03, 2.10), p = 0.21
Mother took fish oil during child’s pregnancy 0.42 (0.17, 1.04), p = 0.06 0.45 (0.10, 1.99), p = 0.29 0.71 (0.15, 3.36), p = 0.66 0.70 (0.15, 3.33), p = 0.65
Mother drank alcohol during child’s pregnancy (any) 1.07 (0.71, 1/62), p = 0.74 0.72 (0.35, 1.48), p = 0.37 1.07 (0.50, 2.35), p = 0.85 0.97 (0.44, 2.16), p = 0.94
Mother drank coffee during child’s pregnancy (any) 1.13 (0.82, 1.57), p = 0.46 0.85 (0.51, 1.42), p = 0.53 0.67 (0.37, 1.21), p = 0.19 0.66 (0.36, 1.22), p = 0.19
Child was breastfed (any) 1.46 (0.94, 2.29), p = 0.094 0.88 (0.44, 1.73), p = 0.70 0.90 (0.41, 1.97), p = 0.79 0.86 (0.39, 1.89), p = 0.71
Length of breastfeeding (if any, weeks)* 1.00 (0.99, 1.00), p = 0.70 1.00 (1.00, 1.01), p = 0.19 1.01 (1.00, 1.01), p = 0.25 1.00 (0.99, 1.01), p = 0.72
Age at commencement of cow’s milk (weeks)* 0.99 (0.98, 1.00), p = 0.043 1.00 (0.99, 1.01), p = 0.88 0.99 (0.98, 1.01), p = 0.45 0.99 (0.98, 1.01), p = 0.30
Mother smokes indoors near child (any) 0.55 (0.25, 1.21), p = 0.14 0.49 (0.21, 1.10), p = 0.082‡ 0.32 (0.10, 1.01), p = 0.052 0.33 (0.10, 1.06), p = 0.063
Father smokes indoors near child (any) 0.51 (0.22, 1.18), p = 0.12 0.52 (0.22, 1.23), p = 0.14‡ 0.22 (0.07, 0.67), p = 0.008 0.26 (0.08, 0.81), p = 0.020
Covariates were added to the logistic regression model sequentially from left to right.
Phenotypic variables that remained significantly different between cases and controls following full covariate adjustment are highlighted in bold.
†Child measures = age, sex, Caucasian ancestry (y/n).
*β coefficients reported for continuous exposures.
** Not adjusted for since same as, or highly significantly correlated with, the exposure variable.
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age at diagnosis was 6.4 years, and therefore the cases
were approximately evenly distributed using this cut-
point. Secondly, there is evidence to suggest that the
underlying biological characteristics of JIA may be differ-
ent between cases grouped in this way, even amongst
cases of the same subtype [18,19].
Additional file 1: Table S1 presents full data on charac-
teristics of younger and older-diagnosed cases. Only a
few statistically significant differences were identified
when these case group definitions were compared. Of
note, the percentage of females was higher in younger
diagnosed cases; this likely reflects the fact that common
subtypes such as oligoarticular JIA that are more com-
monly diagnosed at a younger age are also more often
diagnosed in females [20]. We also noted a difference in
the age of both mothers and fathers at the time of birth
of the case child. Mothers of younger diagnosed cases
were older (β = 1.1; 95% CI 1.0, 1.1; p = 0.015) as were
fathers of younger diagnosed cases (β = 1.1; 95% CI 1.0,
1.1; p = 0.012) at the time of the case birth. However,
these associations did not persist following adjustment
for SEIFA score, and child sex and ancestry. Younger
diagnosed case children were also less likely to have
been born as part of a multiple birth, but not signifi-
cantly so following covariate adjustments. Younger-
diagnosed children were less likely to have a mother or
father who smokes indoors near the child. These differ-
ences were not significant following adjustment for
mother’s completion of high school (as a proxy for
SEIFA score), child sex, and maternal age at birth. Insuf-
ficient data was available to add ancestry to the model.
No other statistically significant differences between the
younger and older case groups were observed.
Discussion
The CLARITY JIA Biobank project was established in
response to the paucity of data concerning both the
genetic and environmental risk factors that contribute to
JIA disease risk. Since its inception, the study team have
achieved high recruitment rates. For cases, this demon-
strates the high motivation of case families to participate
in research regarding their disease. For controls in
whom there is generally no such motivation to partici-
pate, we have achieved similarly high recruitment rates.
Recruitment efforts have resulted in near-complete col-
lection of questionnaire data and biospecimens (includ-
ing carefully stored plasma and viable PBMCs) across
all participants.
The data presented in this paper represents parti-
cipants recruited between study commencement and
December 2010. The 12 month lag-time prior to finalisa-
tion of data allowed for the confirmation of diagnosis of
JIA. Eight cases were excluded from analysis (and twocases withdrew) during this 12 month window due to a
change in diagnosis from JIA to ‘other arthritis’ (n = 7)
or ‘ankylosing spondylitis’ (n = 1), and thus the imposed
diagnosis window allowed a more accurate summation
of data in confirmed JIA cases.
Collection of healthy paediatric control samples, espe-
cially where a blood sample is required, is a difficult task.
Ideally, the control participants would be carefully
sampled to accurately reflect the demographics of the
entire Victorian population. However, in studies that
require the collection of a biospecimen, particularly a
blood sample, hospital-based controls are a necessary
compromise between population-based sampling and
achievement of sufficient recruitment rates. In our set-
ting, we will have the ability to assess the robustness of
full study findings to hospital control use through the
collection of data on reason for minor surgery (e.g.
infection related vs non-infection related admissions),
and an ability to compare control demographic and birth
data to that collected for all Victorian live births to the
Victorian Perinatal Data Collection Unit [21].
Overall, these early case-control data comparisons
demonstrate that the case and control groups are similar
in many of their pregnancy, birth, and early life charac-
teristics. Maternal SEIFA score proved to be an import-
ant covariate; with shifts in ORs and p values often
evident upon adjustment for this variable. Some case-
control differences were evident, even after adjustment
for maternal SEIFA score, child age, sex and ancestry,
and maternal age at the child’s birth. These included a
higher level of education, but a lower number of hours
in paid work for mothers of cases, possibly reflecting an
increased parental care burden on mothers of children
with chronic illness. A higher number of parents of cases
were married at interview. Other characteristics were
not different between cases and controls following cov-
ariate adjustments.
Smoking has been identified as a strong environmental
risk factor for adult rheumatoid arthritis (RA) [22]; how-
ever our data shows no increase in the risk of JIA related
to tobacco smoke exposure, either in utero, or during
early life. At interview, cases were less likely to be
exposed to active parental smoking, but disease-related
changes to parent behaviour may partly underlie this.
Three small studies were published in the mid-1990’s
that examined the impact of commencement and dur-
ation of breastfeeding on JIA disease risk. Each study
carried significant limitations in terms of design and
sample size (reviewed in [5]). However, two studies
found that there was no difference in the commence-
ment of breastfeeding [23,24], whilst one concluded that
children with ‘juvenile rheumatoid arthritis’ were less
likely to have been breastfed [25]. In relation to duration,
one study found that longer duration of breastfeeding
Ellis et al. Pediatric Rheumatology 2012, 10:37 Page 9 of 10
http://www.ped-rheum.com/content/10/1/37was protective against JIA [24], while one study found
that duration was longer in children with polyarticular
JIA compared to ‘pauciarticular’ (oligoarticular) JIA [23].
Our data showed a slightly higher rate of breastfeeding
commencement in JIA children, although this difference
was not significant. There were no differences in the
duration of breastfeeding between cases and controls in
our dataset. Overall, our data does not support a role for
commencement or duration of breastfeeding in deter-
mining disease risk. There was some evidence for earlier
introduction of cow’s milk in cases; earlier introduction
of cow’s milk protein has been associated with other
paediatric immune disorders [26]. However, the differ-
ence was not significant following adjustment for SEIFA
score, suggesting this difference might be more related
to socio-economic status.
There is a growing body of literature as to the role of
vitamin D in autoimmune disease, including RA
(reviewed in [5]). Interestingly, we found a trend towards
a protective effect of the use of vitamin D and fish oil
nutritional supplements during pregnancy, although this
effect was not significant on adjustment for covariates.
Additionally, the role of microbial exposures and infec-
tions in early life as potential environmental factors
that protect against autoimmune disease (the hygiene
hypothesis) [27] and/or act as disease triggers [28] is of
interest. Caesarean delivery has been associated with
increased risk of childhood immune disorders, and it has
been proposed that this may be related to a lack of
exposure to vaginal and intestinal flora during birth [29].
Our data shows no risk association with caesarean birth.
However, a more complete examination of the role of
microbial exposure on JIA risk is required to properly
address such hypotheses.
Conclusions
In summary, CLARITY is an internationally unique col-
lection of clinical and environmental epidemiological
data matched with biospecimens collected from children
with JIA, and from healthy control children. Recruit-
ment is ongoing. The data presented in this paper repre-
sents a series of cases and controls collected over the
first 3 years of recruitment. Cases and controls were
shown to be relatively comparable in terms of pregnancy,
birth, and early life characteristics, and can be assessed
for source population representativeness, providing real
opportunities for novel risk factor identification in this
understudied but burdensome childhood disease.
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